Pfizer to seek FDA authorization of COVID-19 booster shot
Reuters, 09 Jul 2021
Pfizer plans to ask U.S. regulators to authorize a booster dose of its COVID-19 vaccine within the next month, based on evidence of greater risk of reinfection six months after inoculation and the spread of the highly contagious Delta variant.
Reuters brings you the latest business, finance and breaking news video from around the globe. Our reputation for accuracy and impartiality is unparalleled.
Get the latest news on: http://reuters.com/
Follow Reuters on Facebook: https://www.facebook.com/Reuters
Follow Reuters on Twitter: https://twitter.com/Reuters
Follow Reuters on Instagram: https://www.instagram.com/reuters/?hl=en